CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The IDEAS network aims to improve early-stage drug development by training researchers in medical statistics and study design. It focuses on developing efficient methodologies to avoid costly failures in later stages of drug trials through a collaborative, cross-sector approach.
Drug development is a long and costly process which suffers from the major shortcoming that frequently failure is often onlydetermined during the final stage.
Recently, it has been recognised that more care needs to be taken during the early stagesof development to avoid going into lengthy and costly confirmatory studies with ineffective or harmful treatments.
To achievethis goal it is essential to implement efficient methods for the design and analysis of such early development studies.
Theexpe…
UNIVERSITY OF LANCASTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Torino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, Berlin
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
